Symbol Lookup

Tuesday September 02, 2014 12:35 PM ET. Data delayed 15 minutes.
10.23
0.01 (0.10%)
Bid/Lots
10.23/3
Ask/Lots
10.29/3
Open/Prev Close
10.30/10.22
Day Range
10.16-10.45
52-Week Range
9.65-23.25
Vol/Avg Daily Vol
27.8K/76.8K

TD Waterhouse offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

CARA Headlines

Go
Cara Therapeutics Reports Second Quarter 2014 Financial Results
4:44PM ET on Thursday Aug 07, 2014 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced financial results for the second quarter ended June 30, 2014.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors, today announced financia...

Aug 6, 2014

Cara Therapeutics Initiates Proof-of-Concept Phase II Trial of I.V. CR845 in Uremic Pruritus
8:00AM ET on Wednesday Aug 06, 2014 by GlobeNewswire
Companies Mentioned: CARA

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to selectively target peripheral kappa opioid receptors, today announced the dosing of the first dialysis patients in a Phase II trial of an intravenous formulation of its peripherally-selective kappa opioid agonist, CR845, for the treatment of uremic pruritus. The company expects to report top-line data from this trial in the first half of 2015.

Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to selectively target peripheral kappa opioid receptors, today announced the dosing of the first dialysi...

Peers Headlines

Today

Threshold Pharmaceuticals Announces Presentation and Webcast at the Rodman & Renshaw 16th Annual Global Investment Conference
5 hours ago by Marketwire
Companies Mentioned: THLD

Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present a company overview at the Rodman & Renshaw 16th Annual Global Investment Conference on Tuesday, Septe...

Aug 13, 2014

Sector Update: Health Care Stocks Still Surging Late; InterMune Spiking on Takeover Rumors
3:47PM ET on Wednesday Aug 13, 2014 by Midnight Trader
Companies Mentioned: ITMN, RIGL, OTIC
03:47 PM EDT, 08/13/2014 (MT Newswires) -- Top Healthcare Stocks JNJ +0.96% PFE +0.43% ABT +1.17% MRK +1.31% AMGN +1.10% Healthcare stocks were broadly higher Wednesday with the NYSE Healthcare Sector Index climbing about 0.8% and shares of ...
Sector Update: Health Care
3:46PM ET on Wednesday Aug 13, 2014 by Midnight Trader
Companies Mentioned: ITMN, RIGL, OTIC
03:46 PM EDT, 08/13/2014 (MT Newswires) -- Healthcare stocks were broadly higher Wednesday with the NYSE Healthcare Sector Index climbing about 0.8% and shares of healthcare companies in the S&P 500 advancing about 1.1% as a group. In company new...
Sector Update: Health Cares Stocks Posting Strong Gains; Rigel Pharma Sinks After Scrapping Eye Drug Trial
1:00PM ET on Wednesday Aug 13, 2014 by Midnight Trader
Companies Mentioned: RIGL, OTIC
01:00 PM EDT, 08/13/2014 (MT Newswires) -- Top Healthcare Stocks JNJ +1.07% PFE +0.57% ABT +1.09% MRK +1.26% AMGN +0.59% Healthcare stocks were broadly higher Wednesday with the NYSE Healthcare Sector Index climbing about 0.8% and shares of ...
Sector Update: Health Care
12:59PM ET on Wednesday Aug 13, 2014 by Midnight Trader
Companies Mentioned: RIGL, OTIC
12:59 PM EDT, 08/13/2014 (MT Newswires) -- Healthcare stocks were broadly higher Wednesday with the NYSE Healthcare Sector Index climbing about 0.8% and shares of healthcare companies in the S&P 500 advancing about 1.0% as a group. In company new...
Rigel experimental eye drug fails mid-stage study
7:44AM ET on Wednesday Aug 13, 2014 by Thomson Reuters
Companies Mentioned: RIGL

Aug 13 (Reuters) - Rigel Pharmaceuticals Inc said its experimental drug failed to meet the main goal in a mid-stage study in patients with dry eye dis...

Rigel Pharmaceuticals Says R348 Fails to Meet Primary and Secondary Endpoints And Discontinues Indirect AMPK Activator Program
7:38AM ET on Wednesday Aug 13, 2014 by Midnight Trader
Companies Mentioned: RIGL
07:38 AM EDT, 08/13/2014 (MT Newswires) -- Rigel Pharmaceuticals (RIGL) says R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease. ...
R348 Did Not Meet Endpoints in Phase 2 Dry Eye Study
7:30AM ET on Wednesday Aug 13, 2014 by PR Newswire
Companies Mentioned: RIGL

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that R348, its ophthalmic JAK/SYK inhibitor, did not meet the primary or secondary endpoints in a recently completed Phase 2 clinical study in patients with dry eye disease. The endpoi...

Aug 5, 2014

Sector Update: Health Care Stocks Fall With Broader Markets; Oxford Immunotec Slips After Q2 Revenue Lags Street
4:20PM ET on Tuesday Aug 05, 2014 by Midnight Trader
Companies Mentioned: RIGL, OXFD, ISR
04:20 PM EDT, 08/05/2014 (MT Newswires) -- Top Healthcare Stocks JNJ -0.34% PFE -1.18% ABT -1.44% MRK -1.81% AMGN -0.60% Healthcare stocks were lower this afternoon with the NYSE Healthcare Sector Index declining around 0.9% and shares of he...
Sector Update: Health Care
4:16PM ET on Tuesday Aug 05, 2014 by Midnight Trader
Companies Mentioned: RIGL, OXFD, ISR
04:16 PM EDT, 08/05/2014 (MT Newswires) -- Healthcare stocks were lower this afternoon with the NYSE Healthcare Sector Index declining around 0.9% and shares of healthcare companies in the S&P 500 also were down 0.9% as a group. In company news, ...
← Newer12Older →